Locations:
SearchWhat role does treatment value play in a care path?
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/c5b9a493-c99d-451a-b2f5-d79892897938/Dr_Bolwell_690x380_jpg)
Dr.Bolwell_690x380
Care paths — evidence-based algorithms that define the most effective and efficient treatment in a specific clinical situation — are transforming cancer care at Cleveland Clinic. In this final installment of a video series, Taussig Cancer Institute Chairman Brian Bolwell, MD, discusses how a cancer treatment’s cost and value fits in the care path equation.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Video content: This video is available to watch online.
View video online (https://www.youtube.com/embed/UGGaCoy5Zlk?rel=0&wmode=transparent)
Photography credit: Russell Lee Photography
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients